Skip to content

REGN

Regeneron Pharmaceuticals, Inc.

Long-term debt, 2025
$2.0B
YoY, 2025
+0.1%
5-year CAGR
+0.1%

Long-term debt

Long-term debt by fiscal year

PeriodLong-term debtYoY
2025$2.0B+0.1%
2024$2.0B+0.1%
2023$2.0B+0.1%
2022$2.0B+0.1%
2021$2.0B+0.1%
2020$2.0B—
2019$0—